New anti-parasitic drugs for a global veterinary market

该项目旨在建立一个先进的、与行业相关的管道，用于开发针对在全球数十亿动物中引起严重疾病的有弹性的传染性病原体（寄生虫）的新药。这项研究希望发现杀死寄生虫的新方法，这些寄生虫在宿主动物体内存活，尽管它们受到宿主免疫系统的严重攻击。由此产生的基本认识的转变将导致创新技术或产品，以减轻牲畜动物中寄生虫的负担。预期的社会经济效益包括为最终用户提供商业产品，提高澳大利亚的科学知识基础、生物技术声誉、畜牧生产和转化研究投资。

This project aims to establish an advanced, industry-linked pipeline for the development of new drugs against resilient infectious agents (parasites) that cause serious diseases in billions of animals worldwide. The research expects to discover new ways of killing parasites that survive in their host animal, despite being under severe attack by the host immune system. The resultant shift in fundamental understanding will lead to innovative technologies or products to ameliorate the burden of parasites in livestock animals. Expected socioeconomic benefits include commercial products for end-users and lifting Australia’s scientific knowledge base, reputation in biotechnology, livestock production and investment in translational research.